Longitudinal Investigation of the Risk and Protective Factors of Dating Violence (Dating it Safe)… (NCT07404800) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Longitudinal Investigation of the Risk and Protective Factors of Dating Violence (Dating it Safe) - Firearms
United States1,500 participantsStarted 2024-06-16
Plain-language summary
This sub-study aims to identify key individual (e.g., demographic, socioeconomic, attitudes), relationship, behavioral and situational, trauma related, and neighborhood/community risk and protective factors for gun access, carriage, and use.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Waves 1-13 (years 2010-2024): High school freshman and sophomores located at a designated study school and classroom that returned a signed parent consent form and student assent form.
* Beginning with Wave 10, current partners of participants are eligible to participate.
* Waves 13 - 14 (years 2024-2025) + Firearm injury and violence (FIV) cohort: Original study participants from Waves 1-13 and their current partners will be asked gun usage survey questions. Anyone endorsing gun carriage in Wave 11 will be eligible for an in-depth interview in Waves 13 - 14.
Exclusion Criteria:
\- Anyone not originally consented in 2010 or not a current partner of a participant originally consented in 2010 is not eligible to participate in the research survey. Participants who declined to participate or passed away during previous waves will not be included. Anyone not endorsing gun carriage in Wave 11 will be excluded from in-depth interview invitations.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Identify key individual (e.g., demographic, socioeconomic, attitudes), relationship, behavioral and situational, trauma related, and neighborhood/community risk and protective factors for gun access, carriage, and use.
Timeframe: From 2024 to 2027
2
Qualitative interviews with known gun-carriers
Timeframe: 2024-2027
Trial details
NCT IDNCT07404800
SponsorThe University of Texas Health Science Center, Houston